¿Funciona el test nasal PCR de MRSA si ya empezamos el tratamiento con mupirocina? 🤔 Un nuevo estudio en Clinical Infectious Diseases nos da la respuesta. 🧵👇
1️⃣ El test de PCR nasal para MRSA (Staphylococcus aureus resistente a meticilina) es clave para decidir si quitar o no antibióticos potentes (como vancomicina) en pacientes de UCI. 🏥
2️⃣ Existía la duda: ¿si ya aplicamos pomada de mupirocina (descontaminación universal), el test pierde fiabilidad? 🧪 El estudio analizó a >1000 pacientes.
3️⃣ ✅ El Valor Predictivo Negativo (VPN) se mantiene excelente (>98%) si el test se hace en los primeros 7 días tras iniciar la mupirocina, y es, no inferior a hacerlo antes de empezar la descontaminación. Si el test da negativo, es MUY poco probable que el paciente tenga MRSA.
4️⃣ Después de 7 días, aunque el VPN sigue siendo alto, la sensibilidad cae y el test puede pasar por alto las pocas infecciones verdaderas de MRSA. La PCR detecta ADN aunque las bacterias ya no estén viables, y además la incidencia de MRSA baja con la descontaminación. Por eso su utilidad clínica es muy limitada más allá de una semana.
5️⃣ Este hallazgo refuerza los programas de Optimización de Antibióticos (Stewardship): podemos confiar en la PCR para suspender tratamientos innecesarios incluso tras iniciar la descontaminación… siempre que estemos dentro de los primeros 7 días. 💊🚫
#Medicina #UCI #Antibióticos #Infectología #SaludPública #MRSA #Microbiología #SeguridadPaciente #PCR
👇https://t.co/NRWoLClroo
Congratulations William “Will” Turner! The ACCPpostgrads community looks forward to supporting your pursuit of PGY1 pharmacy residency training at WVU Medicine.
@WestVirginiaU#CongratsPostGrad#RxMatch2026
Nice to see this in print. Supports my practice, though I was surprised by the compliance difference between groups. Reassuring secondary symptomatic VTE was similar (though the study wasn’t powered for this). Would love more head-to-head investigator-led studies. #CardioTwitter
Finally published: the COBRRA trial, the first randomized head-to-head comparison of major DOACs — something the companies would never have done themselves, as a direct confrontation goes beyond their commercial interests. This was driven by independent investigators. The results somewhat support the idea of apixaban being the “safer” DOAC. That said, the list of study limitations is long, and for me, labeling something as “safe” is not enough — after all, even placebo is “safe” when it comes to bleeding. https://t.co/eYehndGzvB
#ICYMI Our latest @SIDPharm Bench to Bedside column is out! Authors discuss phage–antibiotic combinations that may benefit select patients with multidrug-resistant infections.
https://t.co/APj08KCoxG
Have you had to dose antimicrobials in patients with obesity?
The review article shared is my go to resource. Add it to your files to help with future drug dosing. 🧠🧠🧠
https://t.co/YCkKNmaD53
🚨 The CPP Congress Buddy Program is OPEN! 🚨
Headed to the Society of Critical Care Medicine Congress? #PharmICU
👀 First time attendee?
💡 Seasoned pro?
Either way, there’s a spot for you 👇
The 🆕 ACC/AHA Guideline for the Evaluation & Management of Acute Pulmonary Embolism (PE) in Adults is a de novo document offering comprehensive, evidence��based recommendations for the evaluation, management & follow‑up of adults w/ acute PE.
Read more: https://t.co/koqYhnZVIz
🌟 Calling all CPP members! 🌟
The CPP Membership Committee's Congress Buddy Program is here to help you make the most of SCCM Congress! 🤝 Curious about the program? Check out this quick feature from one of our matched pairs!
#SCCM2025#CPP#SCCM#PharmICU#Mentorship
#ScholarlySunday features Dr. MJ Kim and her work on antimicrobial dosing in adults on ECMO. Congratulations MJ and to your collaborators and mentorship team! @IDDocAdi
Fresh out of residency and looking to establish your new practice? Join the CPP Mentor-Mentee Program to be connected with experienced pharmacists to help guide your career path! For more information, see Connect! https://t.co/sTYlv3aYoY
#PharmICU#SCCM
Chapter members: check out your inboxes for our latest newsletter! We have lots going on these days!
👉Ultrasound Course Sept 19
👉@SummitCritCare Sept 20
👉Stomp Out Sepsis 5k Oct 5
👉@BiteSizeMedEd on ECMO in Respiratory Failure Oct 23
Comment below if you’d like more info!
Hear more about the medical care being given in #Ukraine from Marina Rabinovich, PharmD, BCPS, FCCM & Barbara A. McLean, MN, RN, CCNS-BC, NP-BC, CCRN, FCCM in our next @BiteSizeMedEd on July 10th
Register here: https://t.co/lh55kJPl6o
📢 Calling @SCCM_CPP members!
Enhance your research w/ our peer review service. Get journal selection recs, peer reviews & more. If you are interested in submitting a manuscript to the Peer Pre-Review Service, message @PayalKGurnani or @EstevesAly! #CriticalCare#PharmICU
@KirkHerbstreit If UGA and Oregon are better, why are they ranked behind FSU? Is FSU ranked 5th because they’re “5th best” or because it’s what they “deserve” based on their accomplishment and record? Is this an admission that the ranking logic and rules aren’t actually logical and consistent?